SCHEMBL8521537

SCHEMBL8521537

CCCCc1ccc2c(c1)C(CCN)CCC2

nearest known ligand 0.44

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.41
BACE1 P56817 1/20 0.41
SIGMAR1 Q99720 2/20 0.39
HTR2A P28223 3/20 0.39
DRD2 P14416 1/20 0.39
SLC6A2 P23975 1/20 0.39
HTR2C P28335 1/20 0.39
SLC6A4 P31645 1/20 0.39
TAOK1 Q7L7X3 1/20 0.38
TAOK3 Q9H2K8 1/20 0.38
SKP2 Q13309 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8575802 1.00 CTSD (0.41) CTSDBACE1SIGMAR1HTR2ADRD2
SCHEMBL8035005 0.95 SIGMAR1 (0.40) CTSDBACE1SIGMAR1HTR2ADRD2
SCHEMBL8568956 0.92 MTNR1A (0.38) BACE1SIGMAR1
SCHEMBL8568951 0.92 MTNR1A (0.38) BACE1SIGMAR1
SCHEMBL8031506 0.88 SIGMAR1 (0.41) SIGMAR1DRD2
SCHEMBL8521850 0.86 MTNR1A (0.39) SIGMAR1DRD2
SCHEMBL8569498 0.86 MTNR1A (0.39) SIGMAR1DRD2
Hydrochloric Acid SCHEMBL8604303 0.85 MTNR1A (0.39) SIGMAR1DRD2
Hydrochloric Acid SCHEMBL8604302 0.85 MTNR1A (0.39) SIGMAR1DRD2
SCHEMBL8033089 0.82 SIGMAR1 (0.42) SIGMAR1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0721938-B1 Alkyl(hetero)cyclic compounds, process for their preparation and pharmaceutical compositions containing them ADIR (FR) 1999-12-08 EP disclosed
US-5780512-A MELATONINERGIC ADIR ET COMPAGNIE (FR) 1998-07-14 US disclosed
US-5693665-A TREATING MELATONINERGIC DISORDERS ADIR ET COMPAGNIE (FR) 1997-12-02 US disclosed
EP-0721938-A1 Alkyl(hetero)cyclic compounds, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1996-07-17 EP disclosed